Gambardella V, Tarazona N, Cejalvo JM, Lombardi P, Huerta M, Rosello S, Fleitas T, Roda D, Cervantes A. Personalized medicine: recent progress in cancer therapy. Cancers (Basel). 2020;12:1009.

Article  CAS  PubMed  Google Scholar 

Zhang J, Spath SS, Marjani SL, Zhang W, Pan X. Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment. Precis Clin Med. 2018;1:29–48.

Article  PubMed  PubMed Central  Google Scholar 

Shin SH, Bode AM, Dong Z. Precision medicine: the foundation of future cancer therapeutics. NPJ Precis Oncol. 2017;1:12.

Article  PubMed  PubMed Central  Google Scholar 

Malone ER, Oliva M, Sabatini PJB, Stockley TL, Siu LL. Molecular profiling for precision cancer therapies. Genome Med. 2020;12:8.

Article  PubMed  PubMed Central  Google Scholar 

Agur Z, Elishmereni M, Kheifetz Y. Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integration. Wiley Interdiscip Rev Syst Biol Med. 2014;6:239–53.

Article  PubMed  Google Scholar 

Davies MA, Samuels Y. Analysis of the genome to personalize therapy for melanoma. Oncogene. 2010;29:5545–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020;86:102019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ianevski A, Lahtela J, Javarappa KK, et al. Patient-tailored design for selective co-inhibition of leukemic cell subpopulations. Sci Adv. 2021;7(8):eabe4038.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vu TN, Nguyen HN, Calza S, Kalari KR, Wang L, Pawitan Y. Cell-level somatic mutation detection from single-cell RNA sequencing. Bioinformatics. 2019;35:4679–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Subramanian A, Narayan R, Corsello SM, et al. A next generation Connectivity Map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171(1):437-1452 e1417.

Google Scholar 

Stathias V, Turner J, Koleti A, et al. LINCS Data Portal 20: next generation access point for perturbation-response signatures. Nucleic Acids Res. 2020;48:D431–9.

Article  CAS  PubMed  Google Scholar 

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

Article  CAS  PubMed  Google Scholar 

Alizadeh AA, Aranda V, Bardelli A, et al. Toward understanding and exploiting tumor heterogeneity. Nat Med. 2015;21:846–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luond F, Tiede S, Christofori G. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. Br J Cancer. 2021;125:164–75.

Article  PubMed  PubMed Central  Google Scholar 

Ramirez M, Rajaram S, Steininger RJ, et al. Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells. Nat Commun. 2016;7:10690.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaaks P, Coker EA, Vis DJ, et al. Effective drug combinations in breast, colon and pancreatic cancer cells. Nature. 2022;603:166–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Dowling EK, Yan G, et al. Precision combination therapies based on recurrent oncogenic co-alterations. Cancer Discov. 2022;12:1542–59.

Article  PubMed  PubMed Central  Google Scholar 

Athanasiadis P, Ianevski A, Skanland SS, Aittokallio T. Computational pipeline for rational drug combination screening in patient-derived cells. Methods Mol Biol. 2022;2449:327–48.

Article  CAS  PubMed  Google Scholar 

Ryall KA, Tan AC. Systems biology approaches for advancing the discovery of effective drug combinations. J Cheminform. 2015;7:7.

Article  PubMed  PubMed Central  Google Scholar 

Lee MJ, Ye AS, Gardino AK, Heijink AM, Sorger PK, MacBeath G, Yaffe MB. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell. 2012;149:780–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bagheri N, Shiina M, Lauffenburger DA, Korn WM. A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition. PLoS Comput Biol. 2011;7:e1001085.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He L, Bulanova D, Oikkonen J, et al. Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer. Brief Bioinform. 2021;22(6):1.

Article  Google Scholar 

Zhang Q, He Y, Luo N, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019;179:829-845 e820. Gene Expression Omnibus. 2020. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE140228.

Zhang L, Yu X, Zheng L, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018;564:268–72.

Article  CAS  PubMed  Google Scholar 

Guo X, Zhang Y, Zheng L, et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med. 2018;24:978–85.

Article  CAS  PubMed  Google Scholar 

Zhang P, Yang M, Zhang Y, Xiao S, Lai X, Tan A, Du S, Li S. Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer. Cell Rep. 2020;30:4317.

Article  CAS  PubMed  Google Scholar 

Kim N, Kim HK, Lee K, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11:2285.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Durante MA, Rodriguez DA, Kurtenbach S, Kuznetsov JN, Sanchez MI, Decatur CL, Snyder H, Feun LG, Livingstone AS, Harbour JW. Single-cell analysis reveals new evolutionary complexity in uveal melanoma. Nat Commun. 2020;11:496. Gene Expression Omnibus. 2020. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE139829.

Ahmadi S, Sukprasert P, Vegesna R, Sinha S, Schischlik F, Artzi N, Khuller S, Schaffer AA, Ruppin E. The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective. Nat Commun. 2022;13:1613.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fustero-Torre C, Jimenez-Santos MJ, Garcia-Martin S, Carretero-Puche C, Garcia-Jimeno L, Ivanchuk V, Di Domenico T, Gomez-Lopez G, Al-Shahrour F. Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data. Genome Med. 2021;13:187.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maynard A, McCoach CE, Rotow JK, et al. Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell. 2020;182:1232-1251 e1222.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anchang B, Davis KL, Fienberg HG, Williamson BD, Bendall SC, Karacosta LG, Tibshirani R, Nolan GP, Plevritis SK. DRUG-NEM: optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity. Proc Natl Acad Sci U S A. 2018;115:E4294–303.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Francis DM, Manspeaker MP, Schudel A, Sestito LF, O’Melia MJ, Kissick HT, Pollack BP, Waller EK, Thomas SN. Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy. Sci Transl Med. 2020;12:eaay3575.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Shao C, Shi Y, Han W. Lessons learned from the blockade of immune checkpoints in cancer immunotherapy. J Hematol Oncol. 2018;11:31.

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Li F, Jiang F, Lv X, Zhang R, Lu A, Zhang G. A mini-review for cancer immunotherapy: molecular understanding of PD-1/PD-L1 pathway & translational blockade of immune checkpoints. Int J Mol Sci. 2016;17:1151.

Article  PubMed  PubMed Central  Google Scholar 

Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hargadon KM, Johnson CE, Williams CJ. Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors. Int Immunopharmacol. 2018;62:29–39.

Article